14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of XFOR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

X4 Pharmaceuticals Inc. stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 32.88% PDF

The X4 Pharmaceuticals Inc. stock price gained 4.88% on the last trading day (Wednesday, 24th Apr 2024), rising from $1.23 to $1.29. During the last trading day the stock fluctuated 5.74% from a day low at $1.22 to a day high of $1.29. The price has risen in 7 of the last 10 days and is up by 5.74% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 2 million shares were bought and sold for approximately $2.20 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 62.32% during the next 3 months and, with a 90% probability hold a price between $1.81 and $2.61 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

XFOR Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, April 04, 2024, and so far it has fallen -12.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The X4 Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.27 and $1.20. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for X4 Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.22 and $1.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, X4 Pharmaceuticals Inc. finds support just below today's level at $1.22. If this is broken, then the next support from accumulated volume will be at $1.02 and $0.97.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 5.74%. For the last week, the stock has had daily average volatility of 9.83%.

Our recommended stop-loss: $1.22 (-5.15%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (XFOR) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect X4 Pharmaceuticals Inc. to open at $1.27, and during the day (based on 14 day Average True Range), to move between $1.16 and $1.42, which gives a possible trading interval of +/-$0.127 (+/-9.86%) up or down from last closing price. If X4 Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 19.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.31 (1.55%) than the support at $1.22 (5.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

X4 Pharmaceuticals Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.160. We will update the financials statements for X4 Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.95% in the first trading day after earnings release.

Is X4 Pharmaceuticals Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for X4 Pharmaceuticals Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.505 Buy Candidate Upgraded

Predicted Opening Price for X4 Pharmaceuticals Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.27 ( 1.81%) $1.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for XFOR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.34 3.62 %
R2 1.31 1.54 %
R1 1.29 0.264 %
Current price: 1.29
Support S1 1.24 -3.88 %
S2 1.22 -5.16 %
S3 1.20 -7.24 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.47 13.95 %
R2 1.46 13.18 %
R1 1.31 1.55 %
Current price 1.29
Support S1 1.22 -5.43%
S2 1.02 -20.93%
S3 0.97 -24.74%

FAQ

What is the symbol for X4 Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for X4 Pharmaceuticals Inc. is XFOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell X4 Pharmaceuticals Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for X4 Pharmaceuticals Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy X4 Pharmaceuticals Inc. Stock?
X4 Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy X4 Pharmaceuticals Inc. Stock.

What's the current price of X4 Pharmaceuticals Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an X4 Pharmaceuticals Inc. (XFOR) share was $1.29.

What is the 52-week high and low for X4 Pharmaceuticals Inc. Stock?
The 52-week high for X4 Pharmaceuticals Inc. Stock is $2.58 and the 52-week low is $0.572.

What is the market capitalization of X4 Pharmaceuticals Inc. Stock?
As of the Apr 24, 2024, the market capitalization of X4 Pharmaceuticals Inc. is 206.564M.

When is the next earnings date for X4 Pharmaceuticals Inc.?
The upcoming earnings date for X4 Pharmaceuticals Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About X4 Pharmaceuticals Inc.

X4 Pharmaceuticals. X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and my... XFOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT